Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × Cystoscopy × 90 days × Clear all

Sponsor

Conditions

Urinary Bladder Neoplasms 6 Non-Muscle Invasive Bladder Neoplasms 3 Ureteral Neoplasms 1 Neoplasms 1 Muscle Invasive Bladder Urothelial Carcinoma 1 Carcinoma in Situ 1

Interventions

pembrolizumab 20 enfortumab vedotin 12 Magnetic Resonance Spectroscopy 9 avelumab 8 Specimen Handling 8 Nivolumab 8 Gemcitabine 7 Cisplatin 7 atezolizumab 6 Carboplatin 6 sacituzumab govitecan 4 Ipilimumab 4 Docetaxel 4 durvalumab 3 lenvatinib 2 dodecyl maltoside 2 cabozantinib 2 Paclitaxel 2 Mitomycin 2 Immunoglobulin G 2 Fluorodeoxyglucose F18 2 CTLA-4 Antigen 2 Biopsy 2 ALT-803 2 zimberelimab 1 zanidatamab 1 toripalimab 1 tocilizumab 1 tislelizumab 1 tazemetostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡